The updated draft list includes a total of 553 devices, of which 351 are from the cardiovascular category, whereas the other ...

Vutrisiran improved mortality and recurrent CV risks independent of disease severity and improved several other endpoints for ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

KETAMINE deaths have soared by 650 per cent since 2015 – claiming a life almost every week across the UK. Experts warn the ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...

The study, published in Nature Mental Health in February, found that foetal exposure to a drug called acetaminophen, an ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

President Donald Trump is unveiling his sweeping tariff plan on Wednesday, a date he has dubbed “Liberation Day” in his goal ...

Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood ...

Here's why one generic for Lipitor and other recognizable brands may have missed the mark compared to its recognizable ...

RyCarma Therapeutics, Inc., a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases, has appointed Elizabeth Tarka, M.D., ...